Regenerative medicine company Orthocell (ASX:OCC) has announced it has received notification from the Australian Department of Health that its CelGro Dental has been included on the Prostheses List.
Latest News
New Stories
-
Othocell confirms Australian reimbursement for CelGro
March 4, 2021 - -
Kazia Therapeutics signs global agreement for lead candidate
March 4, 2021 - - Latest News -
CSL: 'We have well over one million doses in the fridge'
March 4, 2021 - - Latest News -
Mesoblast boosts cash through private placement
March 4, 2021 - - Latest News -
Research identifies cause and potential treatment for COVID-19-induced heart damage
March 4, 2021 - - Latest News -
AusMedtech 2021 programme launched
March 4, 2021 - - AusBiotech -
Osprey expands US sales coverage with new sales agency agreements
March 2, 2021 - - Latest News